Login
WSLH Toxicology - Blood Lead Proficiency Testing Program Policies

Environmental Health Division home page

WSLH Toxicology: Blood Lead Proficiency Testing Program Policies

Click here for printable format of this document (PDF)

 

Failure to Receive PT Specimens

 

The PT events are generally shipped on the second Monday of the month. The PT program should be notified when specimens have not arrived within one week following the shipment date. A second set of specimens will be sent, and a reporting extension will be granted if necessary. Exact shipment dates for future events are provided in the cover information that accompanies each set of PT specimens, along with the corresponding notification date.

 

 

Specimen Replacement

 

The PT program should also be notified whenever specimens have been destroyed or compromised in any way (e.g. tubes broken). Depending on the date of notification, replacement specimens will be provided, or the participant will receive excused status for the specimen/event. However, this notification must precede the reporting deadline for the event.

 

 

Reporting Deadlines and Extensions

 

Reports must be received or postmarked by the reporting deadline unless a prior request for an extension has been made. This is extremely important for regulatory testing events. Late reports receive a score of zero. Exceptions may be granted, but only in extraordinary circumstances. A signed letter from the Supervisor/Manager/Director of the laboratory detailing such circumstances is required for consideration.

 

 

Challenges to Reports

 

In the event that a PT program report contains incorrect information (e.g. incorrect numerical data or a listing of results not being reported), program staff should be notified as soon as possible. Challenges to information in official program reports must be made within 30 days of the date the report is issued. Incorrect results can be corrected and an amended report issued. Adequate documentation supporting the claim is essential. Appropriate documentation in these cases consists of a fax transmission report clearly showing a successful transmission to the program fax number, along with the reported results. In the absence of a fax transmission form, alternate forms of documentation may be considered at the discretion of program staff, but alternative documentation must be similarly compelling.

 

 

Agency Reports

 

Data from the regulatory program can be forwarded to many regulatory agencies, including CMS (for CLIA ’88), CAP, COLA, OSHA and many state-level agencies. However, it is the participant’s responsibility to inform WSLH which agencies, if any, they designate to receive data. This designation may require identification numbers (e.g. CLIA number) to be provided with the request to forward data.

 

 

Remedial PT

 

In the event that a participating laboratory fails a regulatory testing event, remedial PT events can be requested. Laboratories seeking remedial PT must submit a written request, which includes instructions on the regulatory agency to which results should be forwarded. Labs are allowed no more than two requests in a 12-month period. If the request is made immediately following a regulatory event, formal evaluation of that event must be completed before the remedial PT challenges are provided.

 

 

Target Value Determination and PT Evaluation

 

Several policies govern how target values are determined, and whether the targets are sufficiently robust for evaluation of participant results. Target values for LeadCare® analyzers are determined by the mean of all reported values, following outlier deletion. Target values for all other methods are determined by the mean of a group of selected referee laboratories.

 

  • Consensus, regulatory program
    Federal regulations require >80% consensus of results in a reporting group for formal evaluation of a given specimen. This consensus is virtually always attained by the referee laboratories, but is sometimes not attained in the LeadCare reporting group. When insufficient consensus occurs, participant results in the regulatory program are evaluated as acceptable for the specimen, regardless of the result actually reported. Sufficient examination of program data is needed to prevent an incorrect assumption of good proficiency.


  • Consensus, monthly program
    The monthly program has no required consensus. Consequently, nearly all specimens in both reporting groups are evaluated.


  • Referee/participant deviations
    In rare cases, the mean of participant results will differ considerably from the referee target values. In situations where the deviation exceeds 2 m g/dL, the specimen is not evaluated for laboratories in the referee group. Because LeadCare targets are the mean of participant results, this is not an issue for that reporting group.


  • Alphanumeric results
    PT results should be reported in the same fashion as patient results. In some cases PT specimens have values outside the limits of quantitation for the laboratory. In these cases, it is appropriate to report alphanumeric results, i.e. >X or 65 m g/dL would be evaluated as acceptable for a specimen with a target value of 60 m g/dL, since the acceptable range extends to 66 m g/dL, which is >65 m g/dL.

    When results used in target value determination consist of a mix of alphanumeric and quantitative results, at least 80% of the results must be in one of the two forms for a target value to be defined. In the event that this proportion is not attained, a target value is not determined. When this occurs, all participant results in the regulatory program are deemed acceptable. Results in the monthly program are simply not evaluated.